NCTU Professor and Lithuanian Medical Delegation Visit Bioptik Technology to Explore Medical Technology Development and International Collaboration Opportunities

On October 30, 2026, a professor from National Yang Ming Chiao Tung University and distinguished guests from Lithuania’s medical community visited Bioptik Technology for an exchange and company tour. The delegation was welcomed by the company’s General Manager, Tu Yao-Jen, who introduced Bioptik’s corporate history, medical device R&D achievements, and healthcare-related products.

During the visit, both parties exchanged insights on medical technology applications, healthcare development, and potential international collaboration opportunities, particularly regarding blood glucose monitoring systems and wound care dressings. The delegation also toured Bioptik’s manufacturing facilities to gain a deeper understanding of the company’s technical capabilities in medical device research, development, and manufacturing.

Lithuania’s Healthcare Market Overview

According to data from 2024–2025, Lithuania presents promising market opportunities in diabetes care, home blood glucose monitoring, and wound care.

Diabetes Care Market

According to the International Diabetes Federation (IDF), approximately 210,600 adults aged 20–79 in Lithuania were living with diabetes in 2024. The adult diabetes prevalence rate was approximately 7.5%, with an estimated 28.5% of cases remaining undiagnosed.

Blood Glucose Monitoring Demand

According to the Lithuanian National Health Insurance Fund (NHIF), approximately 127,500 people with diabetes used reimbursed medical supplies in 2024, indicating sustained demand for blood glucose monitoring products and chronic disease management.

Wound Dressing Market

According to Euromonitor''''s 2025 market report, Lithuania''''s wound care market is expected to experience moderate growth. Key growth drivers include an aging population, ongoing demand for everyday wound care, and increasing interest in skin-friendly and advanced wound dressing products.

As a member of the European Union, Lithuania has a well-established healthcare system. With an aging population and increasing demand for chronic disease management, the country presents promising market opportunities for wound care and blood glucose monitoring products.

In the wound care sector, there is growing interest in everyday wound management, skin-friendly dressings, and advanced wound care solutions. In diabetes care, Lithuania has approximately 210,000 adults living with diabetes, supporting sustained demand for home blood glucose monitoring systems and related medical supplies.

During the visit, both parties discussed Bioptik Technology''s wound dressing products and multi-functional blood glucose monitoring systems, exploring potential opportunities for introducing these products to Lithuania and the broader European market.

Bioptik remains committed to expanding its global partnerships and strengthening international cooperation. Through this exchange, the company aims to foster closer connections between the healthcare industries of Taiwan and Lithuania, while exploring new opportunities for medical technology collaboration and international market development.